Brugós, B.; Csirmaz, A.; Major, T.; Bereczky, Z.; Gindele, R.; Balogh, G.; Kacska, S.; Sipos, P.; Illés, Á.; Pfliegler, G.
Antiangiogenic Treatment of Patients with Hereditary Hemorrhagic Telangiectasia: Experience of a Hungarian Center. J. Clin. Med. 2025, 14, 8160.
https://doi.org/10.3390/jcm14228160
AMA Style
Brugós B, Csirmaz A, Major T, Bereczky Z, Gindele R, Balogh G, Kacska S, Sipos P, Illés Á, Pfliegler G.
Antiangiogenic Treatment of Patients with Hereditary Hemorrhagic Telangiectasia: Experience of a Hungarian Center. Journal of Clinical Medicine. 2025; 14(22):8160.
https://doi.org/10.3390/jcm14228160
Chicago/Turabian Style
Brugós, Boglárka, Angéla Csirmaz, Tamás Major, Zsuzsanna Bereczky, Réka Gindele, Gábor Balogh, Sándor Kacska, Péter Sipos, Árpád Illés, and György Pfliegler.
2025. "Antiangiogenic Treatment of Patients with Hereditary Hemorrhagic Telangiectasia: Experience of a Hungarian Center" Journal of Clinical Medicine 14, no. 22: 8160.
https://doi.org/10.3390/jcm14228160
APA Style
Brugós, B., Csirmaz, A., Major, T., Bereczky, Z., Gindele, R., Balogh, G., Kacska, S., Sipos, P., Illés, Á., & Pfliegler, G.
(2025). Antiangiogenic Treatment of Patients with Hereditary Hemorrhagic Telangiectasia: Experience of a Hungarian Center. Journal of Clinical Medicine, 14(22), 8160.
https://doi.org/10.3390/jcm14228160
